Lasa Supergenerics (LASA) Stock Overview

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

LASA Stock Information

Symbol

LASA

Address

Plot no. C-4Ratnagiri, 415722India

Founded

Trading hours

Website

https://lasalabs.com

Country

🇮🇳 India

Phone Number

91 77 9888 8147

Lasa Supergenerics (LASA) Price Chart

Lasa Supergenerics Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.3719424276038503	N/A
Market Cap	$18.63M	N/A
Shares Outstanding	50.09M	-0.40%
Employees	89.00	N/A
Shareholder Equity	1.18B	-25.08%

Valuation	2023	Change
P/E Ratio	-0.05	N/A
P/S Ratio	1.21	N/A
P/B Ratio	0.02	N/A

Growth	2023	Change
Return on Equity	-0.0039	N/A

Earnings	2023	Change
Revenue	$15.45M	N/A
Earnings	-$4.60M	N/A
EPS	-7.71	N/A
Earnings Yield	-20.73	N/A
Gross Margin	0.1489	N/A
Operating Margin	-0.1397	N/A
Net income margin	-0.2981	N/A

Financial Strength	2023	Change
Total Assets	$19.53M	N/A
Total Debt	$2.60M	N/A
Cash on Hand	$284.94K	N/A
Debt to Equity	0.0046	18.59%
Cash to Debt	0.1098	-87.14%
Current Ratio	0.9179	-38.04%